Trial intelligence / Profile preview

Symbicort vs Mono-products in Asthmatic Children (SEEDLING 40/4.5)

NCT00651547Phase 3Completed

Sponsor
AstraZeneca
Start
Jul 2002
Modality
Orthosteric Ligands
01

Overview

A Phase 3 trial of budesonide, formoterol in asthma, sponsored by AstraZeneca. Started Jul 2002; status: completed.

02

Drugs

budesonideformoterol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT00651547.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00651547.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call